WASHINGTON, April 8 (UPI) — The U.S. Food and Drug Administration says it has approved the first generic versions of two drugs used for the treatment of hypertension.
FDA officials said they have approved losartan potassium tablets and losartan potassium and hydrochlorothiazide tablets — a combination drug — that are the generic equivalents of Cozaar and Hyzaar tablets, in that order.
Cozaar and Hyzaar are widely-used anti-hypertensive drugs. The FDA said the generic losartan products will carry the same safety warnings as their brand counterparts, including a boxed warning against the use of these products during the second and third trimesters of pregnancy.
The generic drugs are manufactured in differing strengths by various companies, including TEVA Pharmaceuticals USA, Mylan Pharmaceuticals Inc., Roxane Laboratories Inc. and Torrent Pharmaceuticals Ltd.
Copyright 2010 United Press International, Inc. (UPI). Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI’s prior written consent.